Latest filing published 19 May 2011 for Antares Pharma, INC..
Insider track record
No signal scores available.
Peter L. Sadowski: trading record in brief
Peter L. Sadowski discloses dealings in Antares Pharma, Inc. to SEC (Form 4). We count 8 filings; the first trade dates from 14 May 2008 and the latest from 17 May 2011.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 19 May 2011 came the latest disclosure, a share grant in Antares Pharma, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter L. Sadowski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 32,000 sharesCommon StockSEC:0001140361-11-028828:0
- 13,418 sharesCommon StockSEC:0001140361-11-013087:0
- 8,413 sharesCommon StockSEC:0001140361-10-045685:0
- 19,615 sharesCommon StockSEC:0001140361-10-008213:0
- 12,500 sharesCommon StockSEC:0001140361-09-025986:0
- 12,500 sharesCommon StockSEC:0001016169-09-000047:0
- 12,500 sharesCommon StockSEC:0001016169-09-000025:0
- 25,000 sharesCommon StockSEC:0001016169-08-000041:0
8 of 8 declarations
